Clinical Efficacy of Adjuvant Chemotherapy in Advanced Upper Tract Urothelial Carcinoma (pT3-T4): Real-World Data from the Taiwan Upper Tract Urothelial Carcinoma Collaboration Group

Clinical Efficacy of Adjuvant Chemotherapy in Advanced Upper Tract Urothelial Carcinoma (pT3-T4): Real-World Data from the Taiwan Upper Tract Urothelial Carcinoma Collaboration Group

The clinical efficacy of adjuvant chemotherapy in upper tract urothelial carcinoma (UTUC) is unclear. We aimed to assess the therapeutic outcomes of adjuvant chemotherapy in patients with advanced UTUC (pT3-T4) after radical nephroureterectomy (RNU). We retrospectively reviewed the data of 2108 pati...

Full description

Bibliographic Details
Main Authors: Chung-Yu Lin, Han-Yu Weng, Ta-Yao Tai, Hsi-Chin Wu, Wen-Chi Chen, Chung-Hsin Chen, Chao-Yuan Huang, Chi-Wen Lo, Chih-Chin Yu, Chung-You Tsai, Wei-Che Wu, Yuan-Hong Jiang, Yu-Khun Lee, Thomas Y. Hsueh, Allen W. Chiu, Bing-Juin Chiang, Hsu-Che Huang, I-Hsuan Alan Chen, Yung-Tai Chen, Wei-Yu Lin, Chia-Chang Wu, Yao-Chou Tsai, Hsiang-Ying Lee, Wei-Ming Li
Format: Article
Language:English
Published: MDPI AG 2022-02-01
Series:Journal of Personalized Medicine
Subjects:
upper tract urothelial carcinoma
chemotherapy
prognosis
Online Access:https://www.mdpi.com/2075-4426/12/2/226

Internet

https://www.mdpi.com/2075-4426/12/2/226

Similar Items